News on Mesothelioma | Surviving Mesothelioma

Biomarkers | Diagnosis | Genetics | Prognosis | Research

Gene Targeting Slows Aggressive Form of Pleural Mesothelioma
ByAlex Strauss August 14, 2020

Scientists in Vienna are developing a new treatment for a particularly aggressive form of pleural mesothelioma. This form of mesothelioma…

Read More Gene Targeting Slows Aggressive Form of Pleural Mesothelioma
Europe | Immune Systems | Immunotherapy | International | Research | Treatments

Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
ByAlex Strauss August 11, 2020

Two immunotherapy drugs could become the new standard of care for people with non-epithelioid mesothelioma. All forms of malignant mesothelioma…

Read More Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
New Studies | Prognosis | Research

The Peritoneal Cancer Index in Mesothelioma Prognosis
ByAlex Strauss August 9, 2020

The peritoneal cancer index is a valuable prognostic tool and should be considered in mesothelioma treatment planning. That is the…

Read More The Peritoneal Cancer Index in Mesothelioma Prognosis
Europe | International | New Studies | Research | Symptoms | Treatments

Decisions About Pleural Effusion in Mesothelioma: New Tool May Help
ByAlex Strauss August 7, 2020

Researchers in the UK have developed a new tool that may help patients with mesothelioma and other pleural cancers make…

Read More Decisions About Pleural Effusion in Mesothelioma: New Tool May Help
Chemotherapy | Europe | International | Treatments

Electrochemotherapy for Mesothelioma May Relieve Pain, Shrink Tumors
ByAlex Strauss August 4, 2020

There’s new evidence that a technique called electrochemotherapy (ECT) may relieve mesothelioma pain and even shrink tumors. It may be…

Read More Electrochemotherapy for Mesothelioma May Relieve Pain, Shrink Tumors
Diagnosis | New Techniques | Prognosis

Breath Test for Mesothelioma Might Identify Subtypes
ByAlex Strauss July 31, 2020

Researchers in the UK say a breath test for mesothelioma might be able to distinguish between mesothelioma subtypes. There are…

Read More Breath Test for Mesothelioma Might Identify Subtypes
Chemotherapy | Europe | Immunotherapy | International | New Studies | Research | Treatments

Triple Therapy May Become New First-Line Treatment for Mesothelioma
ByAlex Strauss July 29, 2020

A combination of three powerful mesothelioma therapies could become a new first-line treatment for mesothelioma if an upcoming clinical trial…

Read More Triple Therapy May Become New First-Line Treatment for Mesothelioma
Biomarkers | Diagnosis | Prognosis

The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & Monitoring
ByAlex Strauss July 27, 2020

What are the best biomarkers for mesothelioma? The answer is still Soluble Mesothelin-Related Proteins (SMRPs). That is the conclusion of…

Read More The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & Monitoring
Biopsy | Diagnosis | New Studies | Research

Managing Mesothelioma During the COVID-19 Pandemic: New Guidelines
ByAlex Strauss July 24, 2020

New guidance suggests that patients should continue to receive treatment for malignant mesothelioma during the COVID-19 pandemic. Two new reports…

Read More Managing Mesothelioma During the COVID-19 Pandemic: New Guidelines
Immunotherapy | Treatments | Updates

Common Drugs May Impact Mesothelioma Survival After Immunotherapy
ByAlex Strauss July 21, 2020

There is new evidence that taking certain common drugs could negatively impact mesothelioma survival after immunotherapy. Drugs such as NSAIDs,…

Read More Common Drugs May Impact Mesothelioma Survival After Immunotherapy

1 (888) 378-1331

Gene Targeting Slows Aggressive Form of Pleural Mesothelioma

Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care

The Peritoneal Cancer Index in Mesothelioma Prognosis

Decisions About Pleural Effusion in Mesothelioma: New Tool May Help

Electrochemotherapy for Mesothelioma May Relieve Pain, Shrink Tumors

Breath Test for Mesothelioma Might Identify Subtypes

Triple Therapy May Become New First-Line Treatment for Mesothelioma

The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & Monitoring

Managing Mesothelioma During the COVID-19 Pandemic: New Guidelines

Common Drugs May Impact Mesothelioma Survival After Immunotherapy

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES